Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

2.3K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.3K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

2.7K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.7K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

465
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
465
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

1.5K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.5K
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

554
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
554
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

379
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
379

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ABC of oral health. Dental damage, sequelae, and prevention.

BMJ (Clinical research ed.)·2000
Same author

ABC of oral health. Oral health and disease.

BMJ (Clinical research ed.)·2000
Same author

Periodontopathic bacteria in English HIV-seropositive persons.

AIDS patient care and STDs·2000
Same author

Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN): 1. Carcinogen metabolism, DNA repair and cell cycle control.

Oral oncology·2000
Same author

Orofacial disease: update for the dental clinical team: 8. Salivary complaints.

Dental update·2000
Same author

Orofacial disease: update for the dental clinical team: 5. Lumps and swellings.

Dental update·2000
Same journal

Association between area-level deprivation and hospital dental admissions in children under five.

British dental journal·2026
Same journal

The role of multi-acid and traditional acid etching agents on the surface roughness of a polymer-infiltrated ceramic material.

British dental journal·2026
Same journal

Oral health perceptions among elite athletes and elite para-athletes: psychosocial impacts, sports performance.

British dental journal·2026
Same journal

Frank Clare Wilkinson CBE (1889-1979) dental professor in Manchester, Australia and London, second dean of the Eastman Dental Institute.

British dental journal·2026
Same journal

Admissions factors and their associations with performance in dental education: a quantitative study exploring undergraduate admissions at a UK dental school.

British dental journal·2026
Same journal

Dentistry Show Birmingham reflects a profession looking forward.

British dental journal·2026
See all related articles

Related Experiment Video

Updated: Mar 28, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

84.7K

Anti-thrombotic agents

C Scully, N A Robinson

    British Dental Journal
    |December 15, 2015
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Ferric Chloride-induced Murine Thrombosis Models
    10:37

    Ferric Chloride-induced Murine Thrombosis Models

    Published on: September 5, 2016

    23.5K
    Ferric Chloride-induced Thrombosis Mouse Model on Carotid Artery and Mesentery Vessel
    07:26

    Ferric Chloride-induced Thrombosis Mouse Model on Carotid Artery and Mesentery Vessel

    Published on: June 29, 2015

    19.0K

    Related Experiment Videos

    Last Updated: Mar 28, 2026

    The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
    23:33

    The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

    Published on: February 28, 2012

    84.7K
    Ferric Chloride-induced Murine Thrombosis Models
    10:37

    Ferric Chloride-induced Murine Thrombosis Models

    Published on: September 5, 2016

    23.5K
    Ferric Chloride-induced Thrombosis Mouse Model on Carotid Artery and Mesentery Vessel
    07:26

    Ferric Chloride-induced Thrombosis Mouse Model on Carotid Artery and Mesentery Vessel

    Published on: June 29, 2015

    19.0K